Profile data is unavailable for this security.
About the company
AdAlta Limited is an Australia-based clinical-stage biotechnology company. The Company uses its i-body platform to discover and develop protein therapeutics addressing drug targets that are challenging for other technologies. The Company's first-in-class lead asset, AD-214, is being developed for the treatment of idiopathic pulmonary fibrosis (IPF) and other fibrotic diseases, for which current therapies are sub-optimal. AD-214 is an Fc-Fusion protein that contains two AD-114 i-body molecules at the front end, that bind with high affinity to the human target, CXCR4. It is also engaged in developing i-body enabled Chimeric antigen receptor T cell (CAR-T) cells. It co-develops i-bodies as diagnostic imaging agents (i-PET imaging) against Granzyme B, a biomarker of response to immuno-oncology drugs.
- Revenue in AUD (TTM)3.56m
- Net income in AUD-5.04m
- Incorporated2006
- Employees--
- LocationAdalta LtdUnit 15 / 2 Park Drive, BundooraMELBOURNE 3083AustraliaAUS
- Phone+61 39479-5159
- Fax+61 39479-3666
- Websitehttps://adalta.com.au/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioxyne Ltd | 8.65m | -14.17m | 12.28m | 16.00 | -- | 3.94 | -- | 1.42 | -0.0074 | -0.0074 | 0.0044 | 0.0015 | 1.83 | 6.12 | 10.50 | -- | -302.23 | -22.07 | -418.10 | -28.50 | 38.30 | 45.13 | -165.04 | -39.69 | 1.50 | -- | 0.00 | -- | 1,013.05 | 20.97 | -292.69 | -- | -19.86 | -- |
| BTC Health Ltd | 16.03k | -8.26m | 12.32m | 1.00 | -- | 2.27 | 7.46 | 768.35 | -0.0305 | -0.0305 | 0.00005 | 0.0167 | 0.0017 | -- | 0.031 | -- | -89.67 | -23.15 | -91.36 | -24.64 | -- | -- | -51,522.02 | -2,498.18 | -- | -0.0787 | 0.00 | -- | -86.04 | -26.76 | -1,665.01 | -- | -- | -- |
| Tissue Repair Ltd | 457.52k | -3.28m | 13.00m | -- | -- | 0.7548 | -- | 28.41 | -0.0542 | -0.0542 | 0.0076 | 0.2848 | 0.0209 | -- | 7.95 | -- | -14.96 | -- | -15.46 | -- | 98.19 | -- | -716.30 | -- | 25.84 | -- | 0.00 | -- | -- | -- | 38.95 | -- | -- | -- |
| Argent BioPharma Ltd | 1.32m | -17.02m | 13.58m | -- | -- | 8.07 | -- | 10.26 | -3.32 | -3.32 | 0.1003 | 0.0372 | 0.0813 | 0.7078 | 1.58 | -- | -105.32 | -111.29 | -345.98 | -171.05 | 21.87 | 32.52 | -1,295.20 | -632.42 | 0.6561 | -24.85 | 0.4104 | -- | -28.41 | 47.31 | -2.34 | -- | -16.20 | -- |
| Patrys Ltd | 1.70m | -5.12m | 14.40m | 15.00 | -- | 2.87 | -- | 8.50 | -0.0025 | -0.0025 | 0.0008 | 0.0024 | 0.1978 | -- | 0.5828 | -- | -59.77 | -43.96 | -68.99 | -47.06 | -- | -- | -302.26 | -230.44 | -- | -- | 0.00 | -- | -14.45 | 40.52 | -4.15 | -- | -- | -- |
| Cann Group Ltd | 16.45m | -29.28m | 14.70m | 40.00 | -- | 0.2842 | -- | 0.8941 | -0.0724 | -0.0724 | 0.0406 | 0.1161 | 0.1237 | 0.3952 | 7.37 | -- | -22.03 | -22.28 | -34.23 | -24.43 | 21.11 | -- | -178.07 | -407.57 | 0.0861 | -5.88 | 0.5646 | -- | 114.90 | 89.76 | -27.66 | -- | -11.16 | -- |
| Adalta Ltd | 3.56m | -5.04m | 14.89m | -- | -- | 5.43 | -- | 4.18 | -0.0129 | -0.0129 | 0.0092 | 0.0046 | 0.5491 | -- | 4.72 | -- | -77.76 | -67.77 | -195.09 | -103.16 | -- | -- | -141.60 | -160.72 | -- | -57.86 | 0.4533 | -- | 28.18 | 11.17 | 19.96 | -- | -7.47 | -- |
| Medlab Clinical Ltd | 366.64k | -3.94m | 15.07m | 14.00 | -- | -- | -- | 41.11 | -1.73 | -1.73 | 0.1606 | -0.3068 | 0.1069 | -- | 5.82 | -- | -103.72 | -55.07 | -240.52 | -69.75 | 84.77 | 52.86 | -970.74 | -335.43 | -- | -342.19 | -- | -- | -28.90 | -29.83 | 18.55 | -- | -30.00 | -- |
| Calmer Co International Ltd | 2.46m | -4.50m | 15.09m | -- | -- | -- | -- | 6.13 | -0.0083 | -0.0083 | 0.0039 | -0.0005 | 0.655 | 1.34 | 9.62 | -- | -119.81 | -139.15 | -231.33 | -198.55 | 36.03 | 30.26 | -182.94 | -388.81 | 0.482 | -9.36 | 1.22 | -- | -13.00 | 239.43 | 11.40 | -- | -- | -- |
| Radiopharm Theranostics Ltd | 0.00 | -46.82m | 15.65m | -- | -- | 0.5214 | -- | -- | -0.1343 | -0.1343 | 0.00 | 0.0652 | 0.00 | -- | -- | -- | -63.11 | -- | -77.85 | -- | -- | -- | -- | -- | -- | -7.48 | 0.00 | -- | -- | -- | -13.78 | -- | -- | -- |
| Lumos Diagnostics Holdings Ltd | 12.34m | -13.26m | 16.36m | -- | -- | 1.18 | -- | 1.33 | -0.0356 | -0.0356 | 0.0351 | 0.0288 | 0.3418 | 2.24 | 6.37 | -- | -36.70 | -40.15 | -55.14 | -56.67 | 59.73 | 45.97 | -107.38 | -162.90 | 0.479 | -6.25 | 0.4803 | -- | -9.42 | 39.29 | 80.38 | -- | -38.50 | -- |
| Oncosil Medical Ltd | 355.30k | -11.71m | 16.66m | 2.00 | -- | 2.56 | -- | 46.89 | -0.0081 | -0.0081 | 0.0002 | 0.002 | 0.0506 | -- | 7.88 | -- | -166.55 | -57.65 | -234.81 | -64.83 | -426.96 | -- | -3,295.08 | -473.02 | -- | -68.93 | 0.0256 | -- | -59.92 | -37.72 | -5.74 | -- | 40.13 | -- |
| Algorae Pharmaceuticals Ltd | 84.10k | -2.25m | 16.87m | -- | -- | 4.66 | -- | 200.64 | -0.0015 | -0.0015 | 0.00006 | 0.0022 | 0.0245 | -- | 1.79 | -- | -65.51 | -46.12 | -70.91 | -53.52 | -- | -- | -2,678.04 | -591.05 | -- | -136.75 | 0.00 | -- | 1,132.26 | -44.06 | -7.68 | -- | -- | -- |
| Chimeric Therapeutics Ltd | 0.00 | -11.31m | 17.25m | -- | -- | 1.05 | -- | -- | -0.027 | -0.027 | 0.00 | 0.0191 | 0.00 | -- | -- | -- | -45.96 | -- | -69.36 | -- | -- | -- | -- | -- | -- | -10.01 | 0.1596 | -- | -- | -- | -60.40 | -- | -- | -- |
| Amplia Therapeutics Ltd | 4.44m | -4.50m | 17.38m | 1.00 | -- | 1.12 | -- | 3.92 | -0.0226 | -0.0226 | 0.0222 | 0.0572 | 0.2647 | -- | 2.05 | -- | -26.86 | -25.13 | -32.90 | -27.42 | -- | -- | -101.48 | -206.74 | -- | -- | 0.122 | -- | 286.42 | 144.81 | 27.86 | -- | -6.91 | -- |
| Rhythm Biosciences Ltd | 157.67k | -8.63m | 17.40m | -- | -- | 12.72 | -- | 110.37 | -0.0386 | -0.0386 | 0.0007 | 0.0055 | 0.0263 | -- | 1.81 | -- | -144.00 | -106.11 | -169.71 | -125.51 | -1,899.74 | -1,210.71 | -5,473.20 | -6,642.26 | 2.04 | -- | 0.0304 | -- | 814.18 | 28.77 | 6.55 | -- | -20.43 | -- |
Data as of Jun 25 2024. Currency figures normalised to Adalta Ltd's reporting currency: Australian Dollar AUD
